Sara Isani
Overview
Explore the profile of Sara Isani including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
72
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lara O, Smith M, Wang Y, OCearbhaill R, Blank S, Kolev V, et al.
Gynecol Oncol
. 2021 Dec;
164(2):304-310.
PMID: 34922769
Background: Despite significant increase in COVID-19 publications, characterization of COVID-19 infection in patients with gynecologic cancer remains limited. Here we present an update of COVID-19 outcomes among people with gynecologic...
2.
Lara O, Smith M, Wang Y, OCearbhaill R, Blank S, Kolev V, et al.
Cancer
. 2020 Dec;
127(7):1057-1067.
PMID: 33294978
Background: Mounting evidence suggests disproportionate coronavirus disease 2019 (COVID-19) hospitalizations and deaths because of racial disparities. The association of race in a cohort of gynecologic oncology patients with severe acute...
3.
Smith M, Lara O, OCearbhaill R, Knisely A, McEachron J, Gabor L, et al.
Gynecol Oncol
. 2020 Oct;
159(3):618-622.
PMID: 33019984
Objective: Elevated inflammatory markers are predictive of COVID-19 infection severity and mortality. It is unclear if these markers are associated with severe infection in patients with cancer due to underlying...
4.
Samuel D, Nevadunsky N, Miller D, Isani S, Kuo D, Gressel G
Curr Probl Cancer
. 2020 Sep;
45(2):100655.
PMID: 32994074
The use of opioids across all specialties has increased greatly over the last 2 decades and along with it, opioid misuse, overdose and death. The contribution of opioids prescribed for...
5.
Van Arsdale A, Miller D, Kuo D, Isani S, Sanchez L, Nevadunsky N
Gynecol Oncol
. 2019 May;
154(1):156-162.
PMID: 31060820
Background: Obesity confers an overall increased risk for development of endometrial cancer. However there are conflicting reports regarding the effect of obesity on patients' overall and disease specific survival. The...
6.
Gressel G, Dioun S, Richley M, Lounsbury D, Rapkin B, Isani S, et al.
Gynecol Oncol
. 2019 Mar;
152(3):509-513.
PMID: 30876496
Objective: The Patient-Reported Outcomes Measurement Information System (PROMIS®) Network has developed a comprehensive repository of electronic patient reported outcomes measures (ePROs) of major symptom domains that have been validated in...
7.
Samuel D, Gressel G, Isani S, Novetsky A, Nevadunsky N
Gynecol Oncol Rep
. 2018 Jun;
24:36-38.
PMID: 29915795
Background: Venous thromboembolism after open gynecologic surgery is not uncommon, especially in the presence of other risk factors such as obesity, prolonged surgical time or gynecologic malignancy. Case: We present...
8.
Rodriguez-Rodriguez L, Hirshfield K, Rojas V, DiPaola R, Gibbon D, Hellmann M, et al.
Gynecol Oncol
. 2016 Mar;
141(1):2-9.
PMID: 27016222
Objective: To determine the feasibility and clinical utility of using comprehensive genomic profiling (CGP) in the course of clinical care to identify clinically relevant tumor genomic alterations for patients with...
9.
Woods D, McAndrew T, Nevadunsky N, Hou J, Goldberg G, Kuo D, et al.
Int J Med Robot
. 2015 Feb;
11(4):406-12.
PMID: 25708320
Background: To date there have been no comprehensive, comparative assessments of the environmental impact of surgical modalities. Our study seeks to quantify and compare the total greenhouse gas emissions, or...